RxDoctor Payments Data

Brenda Moriarty, APRN

Nurse Practitioner · Zephyrhills, FLNPI 1417610908

Payments from drug & device makers

$5,127in general payments, 2019–2025

Across 263 payments — averaging $19.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$807
  • SK Life Science, Inc.$636
  • Lilly USA, LLC$297
  • Neurocrine Biosciences, Inc.$268
  • UCB, Inc.$261
  • Otsuka America Pharmaceutical, Inc.$236
  • plus $3K from 29 others

What the payments were for

  • Food & beverage$5,127100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,127 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Medicare billing

Part B allowed, 2024
$34,938
Medicare patients
220
Services billed
363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant21$33,637
QuliptaAtogepant15$16,860
Oxtellar XrOxcarbazepine19$10,175
BelsomraSuvorexant11$4,897
Levetiracetam36$2,037
Memantine Hcl71$1,544
Donepezil Hcl93$812
Gabapentin32$723
Carbidopa-LevodopaCarbidopa/Levodopa26$689
Divalproex Sodium ErDivalproex Sodium13$543
Quetiapine Fumarate22$452
Escitalopram Oxalate33$440
Propranolol Hcl11$239
Topiramate17$182
Nortriptyline Hcl17$179

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta$807$50,49736 claims
MerckBelsomra$41$4,89711 claims
Upsher-smith Laboratories LLCTopiramate$172$18217 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Zephyrhills

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →